Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Understand the scenarios where a cash back credit card is the best choice. Make your spending count with this guide.
26,647 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
SpaceX aims to put AI compute in orbit by 2028, a move that could reshape data centers. This article breaks down the ...
KXI powers higher on risk-off flows, yet currency swings across Nestlé, Coca-Cola, Walmart and other holdings threate...
Cerebras Systems’ IPO surge has cooled, steering investors toward Alibaba as a more scalable AI platform. This report...
DraftKings is under renewed scrutiny as it rolls out Predictions and posts a mixed Q1 2026. Our price prediction: dkn...
IBM shares plunged after a softer than expected Q2 outlook, triggering a sharp one day drop. Analysts remain split, w...
Eos Energy Enterprises missed revenue expectations for Q4 2025, sparking a 39% one-day drop and renewed debate about ...
Citi raises AMD's price target to $460 on a $132B CPU forecast through 2030, but keeps a Neutral rating, signaling th...
A stronger-than-expected jobs report unleashed a broad market selloff, wiping $1.4 trillion from S&P 500 valuations a...
Mid-year, Figma faces a volatile path as investors weigh AI-led growth against high valuation. A refreshed price pred...
D-Wave Quantum stock gained momentum this week as investors weighed upcoming results and potential partnerships. This...
AMD sits near a pivotal $420 level as first-quarter results underscore strong data-center demand and a bold AI-driven...